Objectives: The objectives of this study were (1) to measure the 2005 performance of freestanding children's hospital emergency departments (EDs) in the care of children with asthma, bronchiolitis, and croup (ABC) using 5 clinical quality indicators and (2) Results: Corticosteroids were administered in 65.8% (95% confidence interval [CI], 65.2%Y66.2%) of visits for moderate to severe asthma and in 82.5% (95% CI, 82.0%Y83.0%) of visits for croup. Physicians ordered an x-ray in 28.6% (95% CI, 28.1%Y29.0%) of asthma visits, 37.3% (95% CI, 36.7%Y37.9%) of bronchiolitis visits, and in 9.1% (95% CI, 8.7%Y9.5%) of croup visits. Benchmarks for corticosteroid administration were 79% and 92% for asthma and croup, respectively; benchmarks for ordering x-rays were 17% for both asthma and bronchiolitis and 2% for croup. Additional benchmarks for antibiotic administration in the ED for asthma and bronchiolitis were 1% and 2%, respectively.
A lthough nearly 30% of all US emergency department (ED) visits are made by children, there are few national data on the quality of care they receive. 1 Local and regional studies, however, raise quality concerns. Examples include high rates of medication errors, 2Y4 low rates of pain management, 5, 6 and variation in the care of common illnesses including fever, 7 croup, 8 and febrile seizures 9 ; the use of sedation 10 ; and the care of life-threatening emergencies such as splenic injury, 11 diabetic ketoacidosis, 12 and cardiopulmonary resuscitation. 13 Previously, we performed a secondary analysis of the National Hospital Ambulatory Medical Care Survey (NHAMCS) database using clinical quality indicators defined as conditionspecific, systematically developed measures of performance. 14 We found that physicians treating children with asthma, bronchiolitis, and croup (ABC) in US EDs are underutilizing known effective treatments and overutilizing ineffective or unproven therapies and diagnostic tests. 15 The care of children with asthma included underutilization of corticosteroids and overutilization of antibiotics and x-rays. The care of children with bronchiolitis included overutilization of antibiotics and x-rays. The care of children with croup included underutilization of corticosteroids and overutilization of x-rays.
In the context of health care quality measurement, benchmarks are calculated standards for clinical quality indicators that determine the level of performance achieved by the bestperforming organizations. When variability in care has been identified, benchmarks can be used to identify best practices and stimulate quality improvement. Benchmarking is the process of comparing the quality of care to an industry standard or best practice. In the Harvard ED Quality Study, feedback of benchmark information to physicians and subsequent quality improvement efforts led to significant improvement in compliance with process-of-care guidelines and patient-reported measures of quality. 16 The use of guidelines and benchmarking by US Cystic Fibrosis Centers has dramatically improved expected survival and the overall quality of care for children with cystic fibrosis. 17 Recently, the National Committee for Quality Assurance retired the quality measure on the percentage of patients with acute myocardial infarction who receive a prescription for A-blockers because it was no longer needed. 18 The reason is that because of benchmarking and multifocused quality improvement efforts, nearly all US patients now receive A-blockers after acute myocardial infarction.
Although condition-specific quality indicators are available for the emergency care of children, 14 benchmarks for these indicators have not been reported. The absence of benchmarks is therefore a barrier to quality improvement. The methodology for deriving achievable benchmarks of care is defined 19 and has been successfully applied to improve physician performance. 20 Establishing benchmarks for the ED care of children with ABC has the potential to invigorate the quality improvement process and improve care for millions of children with these common respiratory conditions.
Most studies have found that health system (eg, type of hospital) and enabling (eg, physician training) characteristics can be associated with variation in the care of children with asthma, 21 bronchiolitis, 22 and croup. 8 For example, patients presenting with asthma to children's hospital EDs are less likely to undergo chest radiographs than patients presenting to community EDs. 21 Pediatric hospitals also have higher rates of prescribing steroids for asthma at the time of disposition. 21 In addition, emergency medicineYtrained physicians are more likely to order radiographs than pediatricians and pediatric emergency medicineYtrained physicians for croup, 8 and admission rates for bronchiolitis are higher in general hospital EDs than those in children's hospital EDs. 
METHODS
The protocol for the conduct of this study was reviewed and approved by the Children's Mercy Hospitals and Clinics Pediatric Institutional Review Board.
Data Sources
Pediatric Health Information System is an administrative database that includes typical patient demographics (eg, age, sex, payor status, ethnicity, up to 21 diagnoses, and up to 21 procedures) on all inpatient and ED patients, but also includes all of the resources billed to the patient (eg, drugs, images, and laboratory). Pediatric Health Information System is operated by the CHCA (Shawnee Mission, Kan, 66202), a business alliance of 42 North American FCHs. During 2005, 27 FCHs submitted ED data into PHIS. Data quality is a joint effort between CHCA, the FCHs, and Thomson Reuters (the data warehouse partner). Before quarterly data are incorporated into the database, it must pass strict data quality standards. For this study, all data were available from the 27 participating hospitals and included in the analysis.
Study Population
For 2005, 3 study populations were chosen to parallel as closely as possible the groups in our previous study. 15 The first population was children 1 to 19 years old with a diagnosis of moderate to severe asthma. To limit the population to visits representing a moderate to severe exacerbation of asthma, we added another condition to asthma visits. Patients had to have received nebulized albuterol during their ED visit. The second study population was children aged 3 months to 2 years with a diagnosis of bronchiolitis. The third population was children aged 3 months to 3 years with a diagnosis of croup. For each of these conditions, the diagnosis had to appear as a primary diagnosis. We manually translated the International Statistical Classification of Diseases, 10th Revision codes used by Guttmann et al 14 to International Statistical Classification of Diseases, Ninth Revision classifications. See Table 1 for a list of International Statistical Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) codes used.
All medications were identified using the National Drug Code Directory. We used the prefix 1032 for corticosteroids and the prefix 1940 for antiasthmatics/bronchodilators. Radiographs were identified by the variable x-ray.
Race/ethnicity variables categories were white not of Hispanic origin, Hispanic, black not of Hispanic origin, Asian not of Hispanic origin, and other/unknown. The pay-type variable was combined into 4 categories: commercial insurance (private insurance), government (Medicare, Medicaid), self-pay, and other/unknown (worker's compensation, no charge, other, and unknown).
Clinical Quality Indicators
We studied 7 clinical quality indicators. Data for 5 of these indicators were available in both NHAMCS and PHIS. Data for 2 indicators, antibiotic utilization in the ED for asthma and bronchiolitis for FCHs for 2005, were available only in PHIS. All indicators are listed in Table 2 .
Statistical Analysis
To determine how CHCA member FCHs performed on the 5 clinical indicators, we computed rates with 95% exact binomial confidence intervals using the 2005 PHIS data.
Achievable Benchmarks of Care were computed using 2005 data for 7 clinical quality indicators. Achievable Benchmarks of Care is a 3-step method that begins with ranking the hospitals in descending order based on their performance on a measure. 19 Next, the best performing hospitals are selected that comprise at least 10% of the total population. Finally, from these hospitals, the benchmark is computed as the sum of the numerators divided by the sum of the denominators. All statistical analyses were performed using the statistical software SAS v.9.1 (SAS Institute, Inc, Cary, NC).
RESULTS
There were 1,468,607 ED visits to 27 CHCA member FCH EDs in 2005. These hospitals were located in 19 states and the District of Columbia. Table 3 shows the demographics of the population.
Children with ABC meeting the inclusion criteria accounted for 130,386 (8.9 %) of the pediatric ED visits for children younger than 19 years in 2005. There were 85,618 patient visits for moderate to severe exacerbations of asthma, 22,420 visits meeting the inclusion criteria for visits for bronchiolitis, and 22,348 patient visits for croup. Table 4 shows the results of 2005 CHCA member FCH ED performance in caring for children with ABC. Figure 1 is a box-and-whisker plot of CHCA member FCHs showing the quartiles and range of performance among hospitals for 5 indicators. The corresponding 2005 national rates that we previously derived from NHAMCS are also plotted for each indicator. 15 Nationally, steroid use for asthma was similar between the 2 groups. More than 75% of the FCHs had a lower utilization of x-rays in asthma and higher utilization of steroids for croup. All of the FCHs had lower rates of utilization of x-rays for bronchiolitis and croup than those of the national average.
The benchmark performance for 7 clinical quality indicators in 2005 is shown in Table 5 . Also shown are the numbers of hospitals meeting or exceeding each benchmark.
DISCUSSION
This study shows that there is a range, sometimes wide, in performance between the highest and lowest performing CHCA member FCH EDs for the respiratory illness quality indicators studied. However, the performance for most FCHs was better than the national rates for all 5 indicators except for the administration of steroids for moderate to severe asthma. We believe that these data demonstrate that FCHs as a group can be considered industry leaders for the purpose of defining realistic and achievable benchmarks of care for children with ABC. We therefore report the first achievable benchmarks of care for 7 ED clinical performance indicators for these common respiratory illnesses.
There was considerable variation among CHCA hospitals in the utilization of steroids for croup and asthma. This variation was primarily driven by 2 hospitals that had very low rates compared with the other hospitals. Despite the variation, there was a similarity with the national rates of utilization of steroids for asthma. We speculate that there are 2 reasons for this: (1) physicians working in EDs are more familiar with the nationally disseminated National Heart Lung Blood Institute asthma guidelines, and despite a significant amount of evidence, there are no nationally disseminated guidelines for croup; and (2) the recommendations for the ED care of asthma are similar between adults and children. Yet, despite the similarity between the FCH and national ED data, US ED rates are less that those reported from Australia (980%). 24 Although variation in ED care for ABC has been previously reported, 8, 21, 22, 25 all of the health system and enabling factors contributing to the variation in EDs nationally are unknown. By constructing these benchmarks, we hope to enable all EDs to study the factors contributing to their level of performance and implement change to emulate the processes of care associated with best practice.
The benchmarking of performance can occur at several levels, and individual physician performance can be measured. The Institute of Medicine has recommended that hospital EDs appoint a physician pediatric coordinator to provide pediatric leadership for the organization. 1 Recommended responsibilities include overseeing pediatric quality improvement initiatives and ensuring that fellow providers are following clinical practice guidelines. Although this is an important step, research indicates that the effect of implementation at the level of the individual and small provider unit is unlikely to have major national sustainable effects on quality without facilitative changes at payment, policy, and organizational levels. 26 The most successful projects, as exemplified by the CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the American College of Cardiology/American Heart Association Guidelines) quality improvement initiative, have found that feedback on improved patient outcomes and the formation of collaborative teams of providers and administrators are critical for the effective implementation of guidelines and can be accomplished in varied settings. 27 Quality improvement collaboratives such as those formed in the CRUSADE initiative bring together teams from multiple sites to focus on a common problem. A recent systematic review of the effectiveness of collaboratives on improving the quality of care concluded that the evidence, although limited, is positive. 28 In the field of pediatrics, the Vermont Oxford Network and US Cystic Fibrosis Centers are examples of established collaboratives that have significantly improved care and saved lives. We believe that ED learning collaboratives could have similar outcomes. These collaboratives could begin by studying processes related to the care of ABC using the current guidelines, quality indicators, and benchmarks we propose. The use of administrative data is associated with several limitations. The accuracy of the diagnosis cannot be confirmed for any of the conditions. We restricted our study to include the ICD-9-CM codes to obtain our data; however, providers were not instructed to follow any defined diagnostic criteria before making a diagnosis. To distinguish between mild and moderate to severe exacerbations of asthma, we included only visits where nebulized albuterol was administered in the ED in both data sets but could not include triage categories of Bemergent[ or Burgent[ only as was done in our previous study with the NHAMCS data set because PHIS data do not include triage categories. This may have underestimated children with moderate to severe asthma in the PHIS data set especially if metered dose inhalers were used instead of nebulized albuterol. In addition, there might have been a potential classification bias regarding steroid treatment, because some children with asthma are pretreated with steroids before ED arrival. Furthermore, there may be a subgroup of patients with a history of asthma with bronchiolitis in whom steroids are warranted.
It is possible that some of the patients with ABC had comorbidities or other diagnostic considerations (eg, wheezing or stridor thought to be a possible foreign body) where antibiotics or x-rays were indicated. Conversely, it is also possible that some of the patients with asthma or croup had comorbid conditions where steroids were contraindicated. The number of conditions that would have to be examined to do a formal analysis of comorbidities is too large and complex to apply to this study.
Hospitals self-select participation in the PHIS database and therefore the sample may not be representative of all FCHs. In addition, there is a geographical bias in our sample because 83% of the population was from the southern and Midwestern regions. There was a similar geographical bias in our NHAMCS study in which 63% of the population were from the southern and Midwestern regions. 15 Nevertheless, these findings must be generalized with caution.
Pediatric Health Information System and NHAMCS were not designed to be compared. They use differing methodologies for data sampling and collection, and the results for similar variables must be interpreted with caution. The NHAMCS records x-ray utilization as a binary variable. Pediatric Health Information System records the exact x-ray study. We therefore made no statistical comparisons between the 2 databases but show data from NHAMCS merely to illustrate that the performance of the FCHs using PHIS data was comparable or better than reported national averages.
We conclude that variation exists among FCHs in the ED care of children with ABC, but the performance is better than previously reported national averages. We report achievable ED benchmarks, based on objective clinical quality indicators, for the care of 3 common respiratory illnesses in children. We believe that all EDs and health care systems using readily available administrative data can use these benchmarks for performance feedback, comparison, and analysis. This has significant potential to stimulate the process of quality improvement of ED care. Future research should study the implementation and effect of incorporating benchmarks into ED quality improvement activities and identify practices that lead to better outcomes for children with ABC.
